M2 EQUITYBITES-March 17, 2015-Samsung Bioepis submits marketing authorisation application for approval of Remicade
JOHNSON & JOHNSON, AS A RESULT OF THE PROPOSED MERGER between Schering-Plough and Merck, has initiated arbitration proceedings regarding its right to terminate the distribution agreement related to Schering-Plough's rights to Remicade
Revenue for the latest quarter rose to $4.7 billion from $3 billion as sales of the rheumatoid arthritis treatment Remicade
increased 36% to $507 million and the allergy treatment Nasonex increased 8% to $307 million.
Meanwhile, Johnson & Johnson is boosting its sales operation to maintain its market-leading role for Remicade
, an RA treatment that has been available since 1999.
M2 PHARMA-March 17, 2015-Samsung Bioepis submits marketing authorisation application for approval of Remicade
It has been developed as a biosimilar to the anti-inflammatory drug, Remicade
, and is a powder for concentrate for solution for infusion supplied at 100mg infliximab per vial.
Comments: Sales of Remicade
were $491 million in the quarter (+8%) and $2.1 billion for the year (+28%).
(Thousand Oaks CA) and Wyeth (Madison NJ), and Remicade
, made by Johnson & Johnson (New Brunswick NJ) and Schering-Plough Corp.
The major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade
Ustekinumab, offered as an injectable alternative to J&J's own Remicade
, may compete with Abbott Laboratories' Humira, Genentech Inc.'s Raptiva, and Amgen Inc.'s Enbrel.
Contract award: Providing of tender for the supply of "remicade
" by negotiated procedure without a contract notice (ddchpd.spyy 144/2014)
According to the company, it will use the proceeds to support the commercialisation and clinical development of BOW015 (biosimilar to Remicade
), initiate an additional Phase 3 clinical trial for BOW015 in Europe, support its ongoing development activities for BOW050 (biosimilar to Humira) and BOW030 (biosimilar to Avastin).